Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 3218313, 13 pages
http://dx.doi.org/10.1155/2016/3218313
Review Article

Diabetic Osteoporosis: A Review of Its Traditional Chinese Medicinal Use and Clinical and Preclinical Research

1Preclinical Medicine School, Beijing University of Chinese Medicine, Beijing 100029, China
2Chinese Materia Medica School, Beijing University of Chinese Medicine, Beijing 100029, China
3Henan Luoyang Orthopedic Traumatological Hospital, Luoyang 471000, China
4The Research Institute of McGill University Health Center, Montreal, QC, Canada H4A 3J1
5Diabetes Research Center, Beijing University of Chinese Medicine, Beijing 100029, China

Received 3 April 2016; Revised 15 July 2016; Accepted 18 July 2016

Academic Editor: Khalid Rahman

Copyright © 2016 Rufeng Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Epstein, G. Defeudis, S. Manfrini et al., “Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition,” Osteoporosis International, vol. 27, no. 6, pp. 1931–1951, 1931. View at Google Scholar
  2. W.-L. Zhang, H.-Z. Meng, and M.-W. Yang, “Regulation of DMT1 on bone microstructure in type 2 diabetes,” International Journal of Medical Sciences, vol. 12, no. 5, pp. 441–449, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Roy, “Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures,” World Journal of Diabetes, vol. 4, no. 4, pp. 101–113, 2013. View at Publisher · View at Google Scholar
  4. P. Piscitelli, C. Neglia, A. Vigilanza, and A. Colao, “Diabetes and bone: biological and environmental factors,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 22, no. 6, pp. 439–445, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Zhang, W.-H. Yu, and X.-L. Wang, “Effects of Tanggukang on serum free radical metabolism in patients with diabetic osteoporosis,” Journal of Clinical Rehabilitative Tissue Engineering Research, vol. 12, no. 7, pp. 1251–1254, 2008. View at Google Scholar · View at Scopus
  6. W. H. Yu and Y. Zhang, “Effect of Tanggukang Decoction on the metabolism of calcium and phosphourous in the patients of diabetes with osteoporosis,” Zhongguo Zhongyi Jizheng, vol. 18, no. 1, pp. 45–46, 2009. View at Google Scholar
  7. B. Ji, J. Guan, X. Chen et al., “Clinical research of self-made kidney-tonifying and blood circulation-promoting Chinese medicine in patients with diabetic osteoporosis,” Guide of China Medicine, vol. 10, no. 17, pp. 3–4, 2012. View at Google Scholar
  8. X. Shang, S. Xu, Q. Zhou et al., “Clinical observations on the effect of Bushen Tongluo capsule for treatment of diabetic osteoporosis,” China Pharmacist, vol. 13, no. 9, pp. 1329–1330, 2010. View at Google Scholar
  9. X. Shang, P. Xie, X. Guo, and T. Zhang, “The influence of Bushen Tongluo Compound on bone mineral density and balance ability of patients with diabetic osteoporosis,” Captial Medicine, vol. 17, no. 16, pp. 60–61, 2010. View at Google Scholar
  10. Z. D. Gong and C. J. Li, “Clinical research of modified Qing'e pill on diabetic osteoporosis,” Zhongguo Zhongyi Jizheng, vol. 21, no. 9, pp. 1391–1402, 2012. View at Google Scholar
  11. A. Yushanjiang and M. Halida, “Clinical study on effect of Xihongkang for the treatment diabetic osteoporosis,” Chinese Journal of Basic Medicine in Traditional Chinese, vol. 18, no. 9, pp. 1001–1002, 2012. View at Google Scholar
  12. M. Deng, “Clinical studies on the effect of Yishen Zhuanggu Compound for the treatment of type 2 diabetes induced osteoporosis,” Guiyang Journal of TCM College, vol. 35, no. 1, pp. 58–59, 2013. View at Google Scholar
  13. L. Zhang, “Clinical observation on 56 cases of patients with diabetic osteoporosis in using Huqian Pill,” Hebei Journal of TCM, vol. 25, no. 3, p. 180, 2013. View at Google Scholar
  14. R. Liu, Observe the Safety and Efficacy of TCM Gu-Song Decoction to Diabetic Osteoporosis (DOP) Patients, Chengdu University of Chinese Medicine, Chengdu, China, 2013.
  15. C. Hao, “Clinical Study on the effect of Gusong decoction on patient with dibetic osteoporosis,” Asia Pacific Traditional Medicine, vol. 11, no. 10, pp. 117–118, 2015. View at Google Scholar
  16. M. Gao, “Clinical observation of tangmaikang granules combined with alendronate sodium tablets in the treatment of bone metabolism in elderly patients with type 2 diabetes,” China Pharmacy, vol. 23, no. 28, pp. 2658–2660, 2012. View at Google Scholar
  17. Z. Feng, X. Yue, F. Li, Y. Wei, and Z. Li, “Clinical study of the effect of Bushen Huoxue principle on bone metabolism of patients with daibetic osteoporosis,” in Proceedings of the 14th TCM Diabtes Conference, Diabetes Sub-society of China Chinese Medicine Assocation, Zhengzhou, China, 2012.
  18. W. Jia, Z. Wu, and Q. Dong, “Clinical observation of the effect of Jiawei Gutongxian Capasule on the treatment of patients with diabetic osteoporosis,” Hebei Journal of TCM, vol. 28, no. 11, pp. 822–823, 2006. View at Google Scholar
  19. Y. Su, S. Qian, Z. Dong, J. Guo, and A. Zhang, “Clinical observation on QIANGGUBAO for treating 40 cases of diabetic osteoporosis,” Journal of Fujian College of TCM, vol. 11, no. 3, pp. 23–25, 2001. View at Google Scholar
  20. L. Zhao, “50 cases of clinical trials in the treatment of diabetic bone metabolism by self-made Jiangu decoction,” Hei Long Jiang Journal of TCM, vol. 29, no. 1, p. 46, 2000. View at Google Scholar
  21. L. Huang, “Clinical study of the effect of Jiangtang Bushen formulation on bone mineral density and serum C reactive protein on patients with diabetic osteoporosis,” Fujian Journal of TCM, vol. 40, no. 6, pp. 15–16, 2009. View at Google Scholar
  22. H. Shen, J. Huang, and Y. Wang, “Clinical observation of the effect of combination of huolisu oral liqiud and salmon calcitonin on the treatment of old patients with diabetic osteoporosis,” Chinese Journal of Information on TCM, vol. 15, no. 1, pp. 78–79, 2009. View at Google Scholar
  23. F. Yan, Y. Zhang, and Z. Wang, “The effect of Migu decoction on the treatment of patients with type 2 diabetes osteoporosis,” Hebei Medicinal Journal, vol. 34, no. 21, pp. 3340–3341, 2002. View at Google Scholar
  24. Y. You, R. Zhuang, H. Zhao, and Y. Xie, “Clinical therapeutical effect of xianling gubao on patients with diabetic osteoporosis,” Journal of Pharmaceutical Research, vol. 33, no. 4, pp. 113–115, 2014. View at Google Scholar
  25. Y. Zhang, T.-Y. Diao, L. Wang, C.-T. Che, and M.-S. Wong, “Protective effects of water fraction of Fructus Ligustri Lucidi extract against hypercalciuria and trabecular bone deterioration in experimentally type 1 diabetic mice,” Journal of Ethnopharmacology, vol. 158, pp. 239–245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Guo, Y. Li, L. Xue et al., “Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs,” Journal of Ethnopharmacology, vol. 155, no. 3, pp. 1401–1416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Miao, J. Wang, Y. Zhu, C. Yue, and M. Chen, “Experimental study on effect of Salvia miltiorrhiza on alveolar bone metabolism and variation in bone mass in diabetic rats,” China Journal of Chinese Materia Medica, vol. 37, no. 11, pp. 1659–1662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Chen, Z. Lin, H. Chen, and X. Chen, “The protection of tetramethylpyrazine on bone in diabetic osteoporosis rat,” Journal of Putian University, vol. 15, no. 5, pp. 46–49, 2008. View at Google Scholar
  29. L. Zhang, H. Ge, and L. Zhao, “Effects of eucommia leaves lavoids on osteoporosis in castrated rat with diabetes melli,” Chinese Journal of Gerontology, vol. 23, no. 6, pp. 370–372, 2003. View at Google Scholar
  30. J. Liang, H. Chen, W. Pan, and C. Xu, “Puerarin inhibits caspase-3 expression in osteoblasts of diabetic rats,” Molecular Medicine Reports, vol. 5, no. 6, pp. 1419–1422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, H. Pan, and Y. Liang, “Experiment study on protection of Puerarin in diabetic osteoporosis,” Chinese Archives of Traditional Chinese Medicine, vol. 30, no. 4, pp. 848–850, 2012. View at Google Scholar
  32. L. Pei, “The effect of flavonoids of Aralia echinocaulis Hand-Mazz on bone metabolism in the diabteic rats,” in Proceedings of the in 4th International Chinese Medicine and Diabetes Conferences, p. 7, Beijing, China, 2009.
  33. Z. Luo, W. Liang, Z. Luo et al., “Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia,” European Journal of Pharmacology, vol. 670, no. 1, pp. 317–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Pohaci, M. Groza, L. Mareş, M. Ciocoiu, and M. Bǎdescu, “Beneficial dexa-related effects of natural polyphenols on experimentally-induced diabetes mellitus complications,” Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi's, vol. 113, no. 3, pp. 838–844, 2009. View at Google Scholar · View at Scopus
  35. A. N. Shuid, N. Mohamed, I. N. Mohamed et al., “Nigella sativa: a potential antiosteoporotic agent,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 696230, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. F. Altan, “Effects of Nigella sativa and human parathyroid hormone on bone mass and strength in diabetic rats,” Biological Trace Element Research, vol. 116, no. 3, pp. 321–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. F. Altan, M. Kanter, S. Donmez, M. E. Kartal, and S. Buyukbas, “Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats,” Acta Histochemica, vol. 109, no. 4, pp. 304–314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Badescu, O. Badulescu, M. Badescu, and M. Ciocoiu, “Mechanism by Sambucus nigra extract improves bone mineral density in experimental diabetes,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 848269, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Du, L. Yin, M. Chen, and Y. Liu, “Effects of Bushen Zhuanggu capsule on bone mineral metabolism and bone density of rats with diabetes osteoporosis,” Chinese Journal of Traditional Medical Science and Technology, vol. 17, no. 4, pp. 293–295, 2010. View at Google Scholar
  40. D. Jiang, B. Wang, Y. Chen, C. Liu, and Z. Liu, “Research on the effects of Shen-xiaokang on the morphology of osteoporosis in Daibetic Rats,” Liao Ning Zhongyi Zazhi, vol. 33, no. 10, pp. 1252–1254, 2006. View at Google Scholar
  41. J. Xu, N. Liang, and Z. Chen, “Research on the effect of bushen jianpi huoxue decoction on bone metabolism in rats due to type 2 diabetes with osteoporosis,” Shanxi Journal of TCM, vol. 31, no. 5, pp. 48–50, 2015. View at Google Scholar
  42. S. Li, M. Xiong, C. Chen et al., “Experimental studies on preventive effect of Shuanghuang Yigu prescription on menopausal diabetses osteoporosis,” Traditional Chinese Drug Research and Clinical Pharmacology, vol. 14, no. 5, pp. 296–298, 2003. View at Google Scholar
  43. Z. Guan, H. Dong, and Q. Dong, “Experimental study on the effect of Tangshukang on the bone metabolism, BMD and bone biomechanics in diabetic osteoporosis rats,” Information on Traditional Chinese Medicine, vol. 27, no. 6, pp. 80–82, 2010. View at Google Scholar
  44. Y. Jiang, Experimental Study on the Effect of Bushen Zhuanggu Capsule on Bone Resorption-Formation Couple Links in Diabetic Osteoporosis Rats, Chengdu University of Chinese Medicine, Chengdu, China, 2002.
  45. Y. Su, H. Xing, L. Zheng, J. Lin, and X. Chen, “Experiment on the effect of QIANGGUBAO on metabolism of bone collagen in the diabetic osteoporosis rats,” Chinese Journal of Osteoporosis, vol. 12, no. 3, pp. 289–291, 2006. View at Google Scholar
  46. I. Takamoto and T. Kadowaki, “Diabetes and osteoporosis,” Clinical Calcium, vol. 14, no. 2, pp. 255–261, 2004. View at Google Scholar · View at Scopus
  47. Y. B. Guo, L. L. Wang, R. F. Ma et al., “Etiology, pathology and prospects of TCM in osteoporosis treatment,” Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, vol. 17, no. 4, pp. 768–772, 2015. View at Google Scholar
  48. “Preliminary exploration of the TCM theory ‘spleen governs digestion and transportation’,” Journal of Traditional Chinese Medicine, vol. 2, no. 4, pp. 285–288, 1982.
  49. W.-H. Chen, X.-X. Liu, P.-J. Tong, and H.-S. Zhan, “Diagnosis and management of knee osteoarthritis: Chinese medicine expert consensus (2015),” Chinese Journal of Integrative Medicine, vol. 22, no. 2, pp. 150–153, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. G. Tian, Y. Li, J. S. Li et al., “Effects of therapies for regulating and reinforcing lung and kidney on osteoporosis in rats with chronic obstructive pulmonary disease,” Journal of Traditional Chinese Medicine, vol. 35, no. 2, pp. 175–183, 2015. View at Publisher · View at Google Scholar
  51. D. Ju, M. Liu, H. Zhao, and J. Wang, “Mechanisms of ‘kidney governing bones’ theory in traditional Chinese medicine,” Frontiers of Medicine in China, vol. 8, no. 3, pp. 389–393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. C.-H. Hsu, C.-J. Lee, T.-J. Chien et al., “The relationship between qi deficiency, cancer-related fatigue and quality of life in cancer patients,” Journal of Traditional and Complementary Medicine, vol. 2, no. 2, pp. 129–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. Z.-Z. Yang, W. Liu, F. Zhang, Z. Li, and Y.-Y. Cheng, “Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach,” Acta Pharmacologica Sinica, vol. 36, no. 6, pp. 699–707, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. D. D. Zhao, S. H. Gao, Q. Q. Mu, P. J. Qin, and F. F. Mo, “Theoretical study on treating type 2 diabetes by regulating the liver, spleen and kidney,” Chinese Medicine, vol. 55, no. 3, pp. 205–208, 2014. View at Google Scholar
  55. D.-A. Zhou, Y.-N. Deng, L. Liu, and J.-J. Li, “Effect of kidney-reinforcing and marrow-beneficial traditional Chinese medicine-intervened serum on the proliferation and osteogenic differentiation of bone marrow stromal cells,” Experimental and Therapeutic Medicine, vol. 9, no. 1, pp. 191–196, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Su, F. Zhu, L. Guo, Y. Zhu, W. Li, and X. Xiong, “Retrospective study on Professor Zhongying Zhou's experience in Traditional Chinese Medicine treatment on diabetic nephropathy,” Journal of Traditional Chinese Medicine, vol. 33, no. 2, pp. 262–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Liu, L. Liu, P. Chen et al., “Clinical trials of traditional Chinese medicine in the treatment of diabetic nephropathy—a systematic review based on a subgroup analysis,” Journal of Ethnopharmacology, vol. 151, no. 2, pp. 810–819, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Wang, Y. Li, Y. Guo et al., “Herba Epimedii: an ancient Chinese herbal medicine in the prevention and treatment of osteoporosis,” Current Pharmaceutical Design, vol. 22, no. 3, pp. 328–349, 2016. View at Google Scholar
  59. L. Zhang, Q.-M. Zhang, Y.-G. Wang, D.-L. Yu, and W. Zhang, “The TCM pattern of the six-zang and six-fu organs can be simplified into the pattern of five-zang and one-fu organs,” Journal of Traditional Chinese Medicine, vol. 31, no. 2, pp. 147–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J. K. Chen, Chinese Medical Herbology and Pharmacology, Art of Medicine Press, Industry, Calif, USA, 2010.
  61. K. Nakashima, H. Miyashita, H. Yoshimitsu, Y. Fujiwara, R. Nagai, and T. Ikeda, “Two new prenylflavonoids from Epimedii Herba and their inhibitory effects on advanced glycation end-products,” Journal of Natural Medicines, vol. 70, no. 2, pp. 290–295, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Yuan, Y. Zhang, Y. Ge, M. Yan, R. Kuang, and X. Zheng, “Astragaloside IV inhibits proliferation and promotes apoptosis in rat vascular smooth muscle cells under high glucose concentration in vitro,” Planta Medica, vol. 74, no. 10, pp. 1259–1264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Raoufi, T. Baluchnejadmojarad, M. Roghani, T. Ghazanfari, F. Khojasteh, and M. Mansouri, “Antidiabetic potential of salvianolic acid B in multiple low-dose streptozotocin-induced diabetes,” Pharmaceutical Biology, vol. 53, no. 12, pp. 1803–1809, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Huang, P. Wang, S. Xu et al., “Biological activities of salvianolic acid B from Salvia miltiorrhiza on type 2 diabetes induced by high-fat diet and streptozotocin,” Pharmaceutical Biology, vol. 53, no. 7, pp. 1058–1065, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Li, Z. Xu, Z. Jiang et al., “Hypoglycemic effect of catalpol on high-fat diet/streptozotocin-induced diabetic mice by increasing skeletal muscle mitochondrial biogenesis,” Acta Biochimica et Biophysica Sinica, vol. 46, no. 9, pp. 738–748, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. M. A. Carai, G. Colombo, B. Loi et al., “Hypoglycemic effects of a standardized extract of Salvia miltiorrhiza roots in rats,” Pharmacognosy Magazine, vol. 11, no. 44, supplement 4, pp. S545–S549, 2015. View at Publisher · View at Google Scholar
  67. G. Qiang, X. Yang, L. Shi et al., “Antidiabetic effect of salvianolic acid a on diabetic animal models via AMPK activation and mitochondrial regulation,” Cellular Physiology and Biochemistry, vol. 36, no. 1, pp. 395–408, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. T. W. Lau, F. F. Y. Lam, K. M. Lau et al., “Pharmacological investigation on the wound healing effects of Radix Rehmanniae in an animal model of diabetic foot ulcer,” Journal of Ethnopharmacology, vol. 123, no. 1, pp. 155–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. H. B. Kwak, D. Yang, H. Ha et al., “Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1,” Experimental and Molecular Medicine, vol. 38, no. 3, pp. 256–264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Wang, Y. Li, Y. Guo et al., “Herba epimedii: an ancient Chinese herbal medicine in the prevention and treatment of osteoporosis,” Current Pharmaceutical Design, vol. 22, no. 3, pp. 328–349, 2015. View at Publisher · View at Google Scholar
  71. Q. Bian, J.-H. Huang, Q.-Q. Liang et al., “The osteogenetic effect of astragaloside IV with centrifugating pressure on the OCT-1 cells,” Pharmazie, vol. 66, no. 1, pp. 63–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. Q. Li, Y.-S. Fan, Z.-Q. Gao, K. Fan, and Z.-J. Liu, “Effect of Fructus Ligustri Lucidi on osteoblastic like cell-line MC3T3-E1,” Journal of Ethnopharmacology, vol. 170, pp. 88–95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Wang, J. Zhang, Y. Hong, Y. Feng, M. Chen, and Y. Wang, “Phytochemical and pharmacological review of da Chuanxiong formula: a famous herb pair composed of chuanxiong rhizoma and gastrodiae rhizoma for headache,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 425369, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Zhang, H. Zhang, F. Wang, D. Yang, K. Ding, and J. Fan, “The ethanol extract of Eucommia ulmoides Oliv. leaves inhibits disaccharidase and glucose transport in Caco-2 cells,” Journal of Ethnopharmacology, vol. 163, pp. 99–105, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. C.-Y. Su, Q.-L. Ming, K. Rahman, T. Han, and L.-P. Qin, “Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology,” Chinese Journal of Natural Medicines, vol. 13, no. 3, pp. 163–182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. W. Xie, Y. Zhao, and L. Du, “Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia,” Journal of Ethnopharmacology, vol. 140, no. 2, pp. 345–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Li, H. Pan, and Y. Liang, “Experimental study on the effect of puerarin injection in high glucose treated osteoblast,” Chinese Journal of Traditional Medical Science and Technology, vol. 19, no. 4, pp. 318–319, 2012. View at Google Scholar
  78. X. Yin, L. Li, L.-L. Zheng et al., “Influence of aqueous extract of Aralia echinocaulis Hand.-Mazz on the expression of fracture healing-related factor receptors,” Zhongguo Gu Shang, vol. 24, no. 9, pp. 761–765, 2011. View at Google Scholar · View at Scopus
  79. O. Coskun, M. Kanter, A. Korkmaz, and S. Oter, “Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas,” Pharmacological Research, vol. 51, no. 2, pp. 117–123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Sun and S. Yu, “Research progress of n pharmacological action of quercetin,” Chinese Medicines Journal of Research and Practice, vol. 25, no. 3, pp. 85–88.
  81. M. Luo, D. Luo, and W. Zhao, “Research progress on pharmacological action of quercetiin,” Chinese Journal of Ethnomedicine and Ethnopharmacy, vol. 25, no. 17, pp. 12–14, 2014. View at Google Scholar
  82. A. Teixeira, N. Baenas, R. Dominguez-Perles et al., “Natural bioactive compounds from winery by-products as health promoters: a review,” International Journal of Molecular Sciences, vol. 15, no. 9, pp. 15638–15678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. Z. Guan and Q. Dong, “Study of the effect of Tangshukang for the VDR, TGF-β1, CaBp-D9K mRNA expression on the diabetic osteoporosis rats,” Modern Medicine Journal of China, vol. 12, no. 4, pp. 4–6, 2010. View at Google Scholar
  84. H. Xing, An Experimental Study on the Effect of Qianggubao on the Metabolism of Bone Collagen in Diabetic Osteoporosis Rats, Chinese Internal Medicine, Fujian College of TCM, 2005.
  85. X. Yang, A. J. Mostafa, M. Appleford, L. W. Sun, and X. Wang, “Bone formation is affected by matrix advanced glycation end products (AGEs) in vivo,” Calcified Tissue International, 2016. View at Publisher · View at Google Scholar
  86. V. Huovinen, V. Saunavaara, R. Kiviranta et al., “Vertebral bone marrow glucose uptake is inversely associated with bone marrow fat in diabetic and healthy pigs: [18F]FDG-PET and MRI study,” Bone, vol. 61, pp. 33–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Y. Leung, “Traditional toxicity documentation of Chinese materia medica—an overview,” Toxicologic Pathology, vol. 34, no. 4, pp. 319–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. P. M. Le, A. Benhaddou-Andaloussi, A. Elimadi, A. Settaf, Y. Cherrah, and P. S. Haddad, “The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat,” Journal of Ethnopharmacology, vol. 94, no. 2-3, pp. 251–259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. U. Kalus, A. Pruss, J. Bystron et al., “Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases,” Phytotherapy Research, vol. 17, no. 10, pp. 1209–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. A. K. Maji, S. Pandit, P. Banerji, and D. Banerjee, “Pueraria tuberosa: a review on its phytochemical and therapeutic potential,” Natural Product Research, vol. 28, no. 23, pp. 2111–2127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. N. Santosh, K. Mohan, S. Royana, and T. B. Yamini, “Hepatotoxicity of tubers of Indian Kudzu (Pueraria tuberosa) in rats,” Food and Chemical Toxicology, vol. 48, no. 4, pp. 1066–1071, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Zhou, X. Su, B. Cheng, J. Jiang, and H. Chen, “Comparative study on pharmacological effects of various species of Pueraria,” Zhongguo Zhongyao Zazhi, vol. 20, no. 10, pp. 619–621, 1995. View at Google Scholar · View at Scopus
  93. Z. Zhang, T.-N. Lam, and Z. Zuo, “Radix puerariae: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use,” Journal of Clinical Pharmacology, vol. 53, no. 8, pp. 787–811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. S.-Y. Yu, H.-T. OuYang, J.-Y. Yang et al., “Subchronic toxicity studies of Radix Astragali extract in rats and dogs,” Journal of Ethnopharmacology, vol. 110, no. 2, pp. 352–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. W. Y. W. Lee, L. C. M. Chiu, and J. H. K. Yeung, “Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation,” Food and Chemical Toxicology, vol. 46, no. 1, pp. 328–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Xu, M. Zhang, H. E. Yao, L. Chen, and X. Xie, “Study on the toxic effect of the liposoluble components of Salvia on rat retinal Müller cells,” West China Journal of Pharmaceutical Sciences, vol. 28, no. 5, pp. 453–455, 2013. View at Google Scholar
  97. C. Hu, Y. Huang, X. Wang, C. Sun, T. Luo, and X. Yang, “A toxicity comparative study of eucommia ulmoides seed and bark,” Journal of Jinggangshan University (Natural Science), vol. 36, no. 1, pp. 95–100, 2015. View at Google Scholar
  98. J. Zhang, H. Du, Q. Li, and Y. Ding, “Study advancement about pharmacological andtoxicological of Eucommia ulmoides Oliv,” Journal of Henan University (Medical Science), vol. 33, no. 3, pp. 217–222, 2014. View at Google Scholar